Enantioselective addition of oxazolones to N-protected imines catalysed by chiral thioureas

Matej Žabka, Andrea Malastová and Radovan Šebesta*
Department of Organic Chemistry, Faculty of Natural Sciences, Comenius University, Mlynská Dolina CH-2, SK-842 15 Bratislava, Slovakia. E-mail: radovan.sebesta@fns.uniba.sk

Received 3rd January 2015 , Accepted 16th January 2015

First published on 16th January 2015


Abstract

Hydrogen bond-catalysed aza-Mannich addition of oxazolones to various protected aldimines has been developed. The resulting, highly functionalized, oxazolones contain a quaternary stereogenic centre and can serve as precursors for chiral α,β-diamino acids with different protecting groups on each amino group. The process benefits from the versatile bifunctional thiourea catalysts, which effect the formation of these products in high yields and stereoselectivities.


Enantiomerically pure α-substituted α,β-diamino acids constitute a group of useful building blocks for chiral auxiliaries and biologically active compounds, including peptides with antibiotic activity.1 A number of reports have recently appeared dealing with the preparation of enantiopure α,β-diamino acids by the Mannich reaction starting from oxazolones.2,3 Oxazol-5(4H)-ones are masked amino acid fragments,4,5 widely used in the construction of quaternary α-amino acids.6–15 These procedures, utilizing e.g. TMS-quinine,16 chiral ion-pair catalysts including phosphonium salts,17,18 binaphthyl betaines,19 phosphoric acid derivatives,20 and gold complexes21 give products in excellent yields and stereoselectivities. However, quite complex catalysts or high catalyst loadings are, usually, required. Catalysis using chiral hydrogen-bond donors, particularly thioureas and squaramides, has recently emerged as a frontier of research in asymmetric organocatalysis.22–25 Chiral, bifunctional thiourea catalysts are capable of activating both the electrophile and the nucleophile, leading to an enantioenriched product.26–28 Moreover, they offer superior advantages with respect to their stability and cost. Therefore, we decided to evaluate a series of easily prepared bifunctional thioureas to address the issue of stereoselective formation of α,β-diamino acids by the Mannich reaction between oxazolones and imines.

In this context, we present chiral thiourea catalyzed Mannich type reaction of oxazolones with N-protected aldimines. Such additions have not been described with hydrogen-bonding catalysts so far.

Fig. 1 depicts nine thioureas 1–3,29–32 and 4–5,33 which have been used in this study.


image file: c5ra00092k-f1.tif
Fig. 1 Thiourea catalysts used in this study.

Fig. 2 depicts two squaramide catalysts 6 and 7.34,35


image file: c5ra00092k-f2.tif
Fig. 2 Squaramide catalysts used in this study.

We first screened the reaction between imine 8a and oxazolone 9a and planned to utilize several bifunctional thiourea catalysts, with different amine functionalities (Fig. 1). We tested Jacobsen-type catalysts 1a–c in toluene, which afforded product 10a with poor enantioselectivity (Scheme 1 and Table 1, entries 2–4). Excellent yield and a moderate enantioselectivity were achieved by using Takemoto catalyst (entry 6). Catalyst 3 with no amine functionality did not perform well. These results suggest that both tertiary or secondary amine functional group and an activating, electron-withdrawing substituent on the thiourea resulting in higher acidity are necessary for the good performance of the catalyst.36 Thus cinchona-alkaloid catalyst 4a gave the product in excellent yield and good enantioselectivity (Table 1, entry 9). We have also found that a small excess of the oxazolone (1.2 eq.) was beneficial for the reaction (Table 1, cf. entries 8–10). Structurally similar catalyst 4b with an ethyl group instead of a vinyl group performed equally well as catalyst 4a.


image file: c5ra00092k-s1.tif
Scheme 1
Table 1 Screening of catalysts in the addition of oxazolone 9a to imine 8aa
Entry Catalyst Yieldb (%) drc erd
a Experimental conditions: imine 8a (0.1 mmol), oxazolone 9a (1.2 eq.), catalyst (10 mol%), toluene (0.5 mL), rt, 18 h.b Combined isolated yield of both diastereomers.c Determined by 1H NMR analysis of the crude reaction mixture.d er of the major diastereomer determined by HPLC analysis.e 1 eq. oxazolone was used.f 1.5 eq. oxazolone was used.g Conversion determined by 1H NMR.
1 DABCO 76 4.1[thin space (1/6-em)]:[thin space (1/6-em)]1 0
2 1a 71 2.1[thin space (1/6-em)]:[thin space (1/6-em)]1 51[thin space (1/6-em)]:[thin space (1/6-em)]49
3 1b 49 5.2[thin space (1/6-em)]:[thin space (1/6-em)]1 63[thin space (1/6-em)]:[thin space (1/6-em)]37
4 1c 18g 1.5[thin space (1/6-em)]:[thin space (1/6-em)]1 54[thin space (1/6-em)]:[thin space (1/6-em)]46
5 2a 20g 1.4[thin space (1/6-em)]:[thin space (1/6-em)]1 53[thin space (1/6-em)]:[thin space (1/6-em)]47
6 2b 99 3.7[thin space (1/6-em)]:[thin space (1/6-em)]1 17[thin space (1/6-em)]:[thin space (1/6-em)]83
7 3 25g 0.9[thin space (1/6-em)]:[thin space (1/6-em)]1 59[thin space (1/6-em)]:[thin space (1/6-em)]41
8 4ae 65 1.6[thin space (1/6-em)]:[thin space (1/6-em)]1 77[thin space (1/6-em)]:[thin space (1/6-em)]23
9 4a 82 3[thin space (1/6-em)]:[thin space (1/6-em)]1 90[thin space (1/6-em)]:[thin space (1/6-em)]10
10 4af 80 3.3[thin space (1/6-em)]:[thin space (1/6-em)]1 79[thin space (1/6-em)]:[thin space (1/6-em)]21
11 4b 78 3[thin space (1/6-em)]:[thin space (1/6-em)]1 90[thin space (1/6-em)]:[thin space (1/6-em)]10
12 5 64 1.5[thin space (1/6-em)]:[thin space (1/6-em)]1 37[thin space (1/6-em)]:[thin space (1/6-em)]63


Our next goal was to screen solvents and evaluate concentration effects to achieve higher stereoselectivity. Experiments were typically conducted at 0.2 M concentration. Running the reaction at lower concentration (0.1 M) resulted in lower yield, but the selectivity did not improve (Table 2, entry 1). By using different, non-polar solvents, however, only small change was observed in terms of diastereo- and enantioselectivity (Table 2, entries 3–6). Use of acetonitrile as a more polar solvent led to inferior enantioselectivity, as this solvent can partially disrupt hydrogen bonds (Table 2, entry 7).

Table 2 Screening of solvents in the addition of oxazolone 9a to imine 8aa
Entry Solvent Yield (%) drb erc
a Experimental conditions: imine 8a (0.1 mmol), oxazolone 9a (1.2 eq.), catalyst 4b (10 mol%), solvent (0.5 mL), rt, 18 h.b Determined by 1H NMR analysis of the crude reaction mixture.c er of the major diastereomer determined by HPLC analysis.d 0.1 M solution.e −35 °C to rt.
1 PhMed 55 2.3[thin space (1/6-em)]:[thin space (1/6-em)]1 89[thin space (1/6-em)]:[thin space (1/6-em)]11
2 PhMee 43 2.6[thin space (1/6-em)]:[thin space (1/6-em)]1 89[thin space (1/6-em)]:[thin space (1/6-em)]11
3 CH2Cl2 53 2.3[thin space (1/6-em)]:[thin space (1/6-em)]1 87[thin space (1/6-em)]:[thin space (1/6-em)]13
4 Xylenes 63 3[thin space (1/6-em)]:[thin space (1/6-em)]1 88[thin space (1/6-em)]:[thin space (1/6-em)]12
5 Et2O 72 3.5[thin space (1/6-em)]:[thin space (1/6-em)]1 90[thin space (1/6-em)]:[thin space (1/6-em)]10
6 CHCl3 64 2.6[thin space (1/6-em)]:[thin space (1/6-em)]1 84[thin space (1/6-em)]:[thin space (1/6-em)]16
7 MeCN 64 3[thin space (1/6-em)]:[thin space (1/6-em)]1 70[thin space (1/6-em)]:[thin space (1/6-em)]30


We then proceed to evaluate the reaction with more sterically demanding oxazolone 9b. This substrate provided product 10b with excellent diastereo- and enantioselectivity with catalyst 4a at −5 °C (Table 3, entry 2). Increasing the concentration or adding molecular sieves (4A) did not have any effect on the selectivity (Table 3, entries 3 and 4). Lower catalyst loading (1 and 5 mol%) decreased the yield of product 10b but its diastereomeric and enantiomeric purity remained high (Table 3, entries 5–6). Catalyst 4b afforded slightly inferior result in comparison to catalyst 4a (Table 3, entry 7). The catalyst 5, which is the pseudo-enantiomer of catalyst 4a, provided the product with the opposite stereochemistry in equally high enantiomeric ratio (Table 3, entry 8). Use of the squaramide-derived catalyst 6, analogous to the Takemoto catalyst 2b, led to inferior results (Table 3, entry 9). Squaramide catalyst 7, derived from quinine, also gave the product with slightly lower enantioselectivity (Table 3, entry 10).

Table 3 Catalyst screening in the reaction with oxazolone 9ba

image file: c5ra00092k-u1.tif

Entry Catalyst Yield (%) drb erc
a Experimental conditions: imine 8a (0.1 mmol), oxazolone 9b (1.2 eq.), catalyst 4a (10 mol%), toluene (0.5 mL), rt, 18 h.b Determined by 1H NMR analysis of the crude reaction mixture.c er of the major diastereomer determined by HPLC analysis.d −5 °C, 3 days.e 0.4 M solution.f MS 4A (50 mg) added.g 1 mol%.h 5 mol%.
1 4a 58 8[thin space (1/6-em)]:[thin space (1/6-em)]1 88[thin space (1/6-em)]:[thin space (1/6-em)]12
2 4ad 67 12[thin space (1/6-em)]:[thin space (1/6-em)]1 96[thin space (1/6-em)]:[thin space (1/6-em)]4
3 4ae 78 12[thin space (1/6-em)]:[thin space (1/6-em)]1 93[thin space (1/6-em)]:[thin space (1/6-em)]7
4 4af 78 8[thin space (1/6-em)]:[thin space (1/6-em)]1 93[thin space (1/6-em)]:[thin space (1/6-em)]7
5 4ag 58 8[thin space (1/6-em)]:[thin space (1/6-em)]1 94[thin space (1/6-em)]:[thin space (1/6-em)]6
6 4ah 48 8[thin space (1/6-em)]:[thin space (1/6-em)]1 97[thin space (1/6-em)]:[thin space (1/6-em)]3
7 4b 50 8[thin space (1/6-em)]:[thin space (1/6-em)]1 92[thin space (1/6-em)]:[thin space (1/6-em)]8
8 5 82 8[thin space (1/6-em)]:[thin space (1/6-em)]1 10[thin space (1/6-em)]:[thin space (1/6-em)]90
9 6 67 3[thin space (1/6-em)]:[thin space (1/6-em)]1 33[thin space (1/6-em)]:[thin space (1/6-em)]67
10 7 44 4[thin space (1/6-em)]:[thin space (1/6-em)]1 86[thin space (1/6-em)]:[thin space (1/6-em)]14


We noticed that the product from oxazolone 9b was formed with good enantioselectivity only if it was contaminated by benzoic anhydride impurity. Benzoic anhydride may remain in the oxazolone from its synthesis and it probably forms benzoic acid under the reaction conditions. It is difficult to completely remove it from the oxazolones. When particular care was taken to remove it, the reaction surprisingly proceeded without any stereoselectivity (Table 4, entry 1). The acid may facilitate nucleophile formation from oxazolone as well as activate the imine. In terms of stereoselectivity, the acid helps in better organization of the transition state. Therefore, we screened several acid co-catalysts. Indeed, we found that acid additive is necessary for the good performance of the catalyst, otherwise only racemic mixture was obtained. Benzoic acid afforded the best results in terms of diastereomeric and enantiomeric purity of the product 10b (Table 4, entry 2). Interestingly, use of sodium benzoate also improved the reaction to certain degree (Table 4, entry 3). This indicates involvement of the benzoate anion in the enantio-determining step of the reaction. No improvement was achieved using different acids with varying acidities (entries 4–9). Interestingly, chiral mandelic acid gave the same result when used as racemate or enantiomerically pure. This suggests that the influence of the anion of acid is in overall steric volume rather than any specific interactions in the transition state. A similar, but less pronounced effect of the acid co-catalyst was observed in an aldol addition.37

Table 4 Screening of acid additives in the reaction of oxazolone 9b with imine 8aa
Entry Additive Yield (%) drb erc
a Experimental conditions: imine 8a (0.1 mmol), oxazolone 9b (1.2 eq.), catalyst 4a (10 mol%), additive (10 mol%), toluene (0.5 mL), rt, 18 h.b Determined by 1H NMR analysis of the crude reaction mixture.c er of the major diastereomer determined by HPLC analysis.d 100 mol% used.
1 52 1.2[thin space (1/6-em)]:[thin space (1/6-em)]1 49[thin space (1/6-em)]:[thin space (1/6-em)]51
2 PhCO2H 54 13[thin space (1/6-em)]:[thin space (1/6-em)]1 95[thin space (1/6-em)]:[thin space (1/6-em)]5
3 PhCO2Na 62 4[thin space (1/6-em)]:[thin space (1/6-em)]1 73[thin space (1/6-em)]:[thin space (1/6-em)]27
4 AcOHd 36 6.3[thin space (1/6-em)]:[thin space (1/6-em)]1 91[thin space (1/6-em)]:[thin space (1/6-em)]9
5 TFA 48 5.5[thin space (1/6-em)]:[thin space (1/6-em)]1 85[thin space (1/6-em)]:[thin space (1/6-em)]15
6 2-IC6H4CO2H 65 3[thin space (1/6-em)]:[thin space (1/6-em)]1 77[thin space (1/6-em)]:[thin space (1/6-em)]23
7 4-BrC6H4CO2H 43 5.5[thin space (1/6-em)]:[thin space (1/6-em)]1 85[thin space (1/6-em)]:[thin space (1/6-em)]15
8 (RS)-Mandelic acid 35 9[thin space (1/6-em)]:[thin space (1/6-em)]1 93[thin space (1/6-em)]:[thin space (1/6-em)]7
9 (R)-Mandelic acid 35 9[thin space (1/6-em)]:[thin space (1/6-em)]1 93[thin space (1/6-em)]:[thin space (1/6-em)]7
10 PhCH2CO2H 68 6.5[thin space (1/6-em)]:[thin space (1/6-em)]1 86[thin space (1/6-em)]:[thin space (1/6-em)]14


Next, we varied the sulfonyl protecting group at the imine. Mesyl-protected imine 8b provided product 10c in high yield with excellent enantioselectivity. Differently substituted oxazolones 9b (i-Pr) and 9c (Bn) gave inferior results with mesyl imine 8b. High diastereoselectivity was achieved with naphthyl imine 8c while the enantioselectivity remained high. More sterically demanding imines 8d–e (2,4,6-trimethylphenyl and 2,4,6-tri(isopropyl)phenyl) gave products with high enantiomeric ratios only with oxazolone 9b, rather than with 9a. Fig. 3 depicts structures of all products 10.


image file: c5ra00092k-f3.tif
Fig. 3 Oxazolones 10a–k obtained by the reactions of imine 8 (0.1 mmol), oxazolone 9 (1.2 eq.), catalyst 4a (10 mol%), PhCO2H (10 mol%), toluene (0.5 mL), rt, 18 h; 10b was obtained at −5 °C.

These results show that in order to achieve high selectivity, steric demands of substrates must match. It seems that oxazolones with less sterically demanding substituents (e.g. 9a) should be combined with imines containing smaller protecting group, such as mesyl (8b). On the other hand, more sterically demanding oxazolones need imines with bigger protecting groups.

We have confirmed absolute configuration of compounds 10a and 10b to be (S,R) by comparison of its electronic CD spectra with theoretically calculated ones. Fig. 4 shows spectra for compound 10b; for more details see ESI.


image file: c5ra00092k-f4.tif
Fig. 4 Comparison of theoretical and experimental ECD spectra of derivate (S,R)-10b; red curve – experimental spectrum; blue curve – calculated conformationally averaged spectrum (DFT, M06/def2_TZVP).

With the help of quantum-chemical calculations (HF, 3-21G), we also proposed a possible model of transition state for the addition, which explains observed stereochemistry of products (see ESI).

Azlactones 10 can be cleaved in acidic medium to α,β-diamino acids. The compound 10b afforded acid 11 in quantitative yield (Scheme 2). By comparison of the sign of its optical rotation with literature data, we further confirmed absolute configuration of the azlactone products.16


image file: c5ra00092k-s2.tif
Scheme 2

Conclusions

Hydrogen bond-catalysed Mannich-type addition of oxazolones to protected imines affords highly functionalized oxazolones. These compounds contain quaternary stereogenic centre and can afford chiral α,β-diamino acids with orthogonally protected amino groups. The products were obtained in medium to high yields and stereoselectivities, which depend on the substitution pattern of the starting materials. Relative and absolute configurations of products were determined by NMR and comparison of calculated and measured CD spectra. Stereochemical course of the addition was explained with the help of quantum-chemical calculations.

Acknowledgements

We acknowledge support from the Slovak Grant Agency Vega, grant no. 1/0543/11.

Notes and references

  1. A. Viso, R. Fernández de la Pradilla, A. García and A. Flores, Chem. Rev., 2005, 105, 3167–3196 CrossRef CAS PubMed.
  2. R. G. Arrayás and J. C. Carretero, Chem. Soc. Rev., 2009, 38, 1940–1948 RSC.
  3. J. M. M. Verkade, L. J. C. V. Hemert, P. J. L. M. Quaedflieg and F. P. J. T. Rutjes, Chem. Soc. Rev., 2008, 37, 29–41 RSC.
  4. A.-N. R. Alba and R. Rios, Chem.–Asian J., 2011, 6, 720–734 CrossRef CAS PubMed.
  5. J. S. Fisk, R. A. Mosey and J. J. Tepe, Chem. Soc. Rev., 2007, 36, 1432–1440 RSC.
  6. A. Berkessel, F. Cleemann, S. Mukherjee, T. N. Müller and J. Lex, Angew. Chem., Int. Ed., 2005, 44, 807–811 CrossRef CAS PubMed.
  7. J. Alemán, A. Milelli, S. Cabrera, E. Reyes and K. A. Jørgensen, Chem.–Eur. J., 2008, 14, 10958–10966 CrossRef PubMed.
  8. Y. Hayashi, K. Obi, Y. Ohta, D. Okamura and H. Ishikawa, Chem.–Asian J., 2009, 4, 246–249 CrossRef CAS PubMed.
  9. H. Jiang, M. W. Paixão, D. Monge and K. A. Jørgensen, J. Am. Chem. Soc., 2010, 132, 2775–2783 CrossRef CAS PubMed.
  10. A.-N. R. Alba, X. Companyó, G. Valero, A. Moyano and R. Rios, Chem.–Eur. J., 2010, 16, 5354–5361 CrossRef CAS PubMed.
  11. A.-N. R. Alba, G. Valero, T. Calbet, M. Font-Bardía, A. Moyano and R. Rios, Chem.–Eur. J., 2010, 16, 9884–9889 CrossRef CAS PubMed.
  12. C. K. De, N. Mittal and D. Seidel, J. Am. Chem. Soc., 2011, 133, 16802–16805 CrossRef CAS PubMed.
  13. M. Terada and H. Nii, Chem.–Eur. J., 2011, 17, 1760–1763 CrossRef CAS PubMed.
  14. C.-W. Cai, X.-L. Zhu, S. Wu, Z.-L. Zuo, L.-L. Yu, D.-B. Qin, Q.-Z. Liu and L.-H. Jing, Eur. J. Org. Chem., 2013, 2013, 456–459 CrossRef CAS.
  15. M. Terada, H. Tanaka and K. Sorimachi, J. Am. Chem. Soc., 2009, 131, 3430–3431 CrossRef CAS PubMed.
  16. X. Liu, L. Deng, X. Jiang, W. Yan, C. Liu and R. Wang, Org. Lett., 2010, 12, 876–879 CrossRef CAS PubMed.
  17. D. Uraguchi, Y. Ueki and T. Ooi, J. Am. Chem. Soc., 2008, 130, 14088–14089 CrossRef CAS PubMed.
  18. D. Uraguchi, K. Yoshioka, Y. Ueki and T. Ooi, J. Am. Chem. Soc., 2012, 134, 19370–19373 CrossRef CAS PubMed.
  19. W.-Q. Zhang, L.-F. Cheng, J. Yu and L.-Z. Gong, Angew. Chem., Int. Ed., 2012, 51, 4085–4088 CrossRef CAS PubMed.
  20. S.-H. Shi, F.-P. Huang, P. Zhu, Z.-W. Dong and X.-P. Hui, Org. Lett., 2012, 14, 2010–2013 CrossRef CAS PubMed.
  21. A. D. Melhado, G. W. Amarante, Z. J. Wang, M. Luparia and F. D. Toste, J. Am. Chem. Soc., 2011, 133, 3517–3527 CrossRef CAS PubMed.
  22. R. Ian Storer, C. Aciro and L. H. Jones, Chem. Soc. Rev., 2011, 40, 2330–2346 RSC.
  23. S. J. Connon, Chem. Commun., 2008, 2499–2510 RSC.
  24. B. List and K. Maruoka, Asymmetric Organocatalysis, Workbench Edition, Thieme Chemistry, Stuttgart, 2012 Search PubMed.
  25. J. Alemán, A. Parra, H. Jiang and K. A. Jørgensen, Chem.–Eur. J., 2011, 17, 6890–6899 CrossRef PubMed.
  26. A. G. Doyle and E. N. Jacobsen, Chem. Rev., 2007, 107, 5713–5743 CrossRef CAS PubMed.
  27. W.-Y. Siau and J. Wang, Catal. Sci. Technol., 2011, 1, 1298–1310 CAS.
  28. Z. Zhang and P. R. Schreiner, Chem. Soc. Rev., 2009, 38, 1187–1198 RSC.
  29. A. G. Wenzel and E. N. Jacobsen, J. Am. Chem. Soc., 2002, 124, 12964–12965 CrossRef CAS PubMed.
  30. S. E. Reisman, A. G. Doyle and E. N. Jacobsen, J. Am. Chem. Soc., 2008, 130, 7198–7199 CrossRef CAS PubMed.
  31. K. Dudziński, A. M. Pakulska and P. Kwiatkowski, Org. Lett., 2012, 14, 4222–4225 CrossRef PubMed.
  32. A. Berkessel and B. Seelig, Synthesis, 2009, 2113–2115 CrossRef CAS PubMed.
  33. B. Vakulya, S. Varga, A. Csámpai and T. Soós, Org. Lett., 2005, 7, 1967–1969 CrossRef CAS PubMed.
  34. H. Konishi, T. Y. Lam, J. P. Malerich and V. H. Rawal, Org. Lett., 2010, 12, 2028–2031 CrossRef CAS PubMed.
  35. W. Yang and D.-M. Du, Org. Lett., 2010, 12, 5450–5453 CrossRef CAS PubMed.
  36. G. Jakab, C. Tancon, Z. Zhang, K. M. Lippert and P. R. Schreiner, Org. Lett., 2012, 14, 1724–1727 CrossRef CAS PubMed.
  37. R. P. Singh, B. M. Foxman and L. Deng, J. Am. Chem. Soc., 2010, 132, 9558–9560 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available: Experimental procedures, characterisation data, and computational details. See DOI: 10.1039/c5ra00092k

This journal is © The Royal Society of Chemistry 2015
Click here to see how this site uses Cookies. View our privacy policy here.